Prospective observational study to investigate the predictors of trastuzumab induced cardiac toxicity in breast cancer patients with perioperative chemotherapy

Prospective observational study to investigate the predictors of trastuzumab induced cardiac toxicity in breast cancer patients with perioperative chemotherapy - predictors of trastuzumab induced cardiac toxicity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016962

Enrollment

Registered

2015-04-01

Start date

2015-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with breast cancer undergoing anthracycline and trastuzumab as perioperative chemotherapy

Exclusion criteria

Exclusion criteria: Patients unsuitable condition for this study judged by the investigator

Design outcomes

Primary

Measure	Time frame
Cardiomyopathy defined as incidence of cardiotoxicity, heart failure admission, and myocardial markers	—

Countries

Japan

Contacts

Public ContactMoe Tsuda

Graduate School of Medicine Kyoto Universit Breast Surgery

moe1985@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results